advertisement

Cancer

22 September 2010

Staying on Gleevec Seems to Help Gastro Cancer Patients

Study patients whose therapy was interrupted had more disease progression

This article has not necessarily been edited by Health24.

The patients were assessed every three months with CT scans. The median time to disease progression was nine months among patients whose treatment was interrupted and was not reached in the group who continued treatment, the investigators found.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit cansa.org.za.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules